The following interactive courses are available for P.A.C.E. credit. In order to receive your P.A.C.E. certificate, you must:
- Complete the course material.
- Take and pass a final exam. If you do not pass the exam, you must retake the course to attempt the exam again.
- Complete the online evaluation.
New York Blood Center Enterprises is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program.
(eLearning courses are best viewed using Chrome as a browser.)
New eLearning Course Available!
Update on Donor Gender Identity and Individualized Risk-based Assessment
Author: Nancy Van Buren, MD & Jed Gorlin, MD, MBA
P.A.C.E. Contact Hours: 0.5
Level of Instruction: Intermediate
Course Objectives:
- Identify the reasons for the donor deferral criterion related to men who have sex with men (MSM) and women who have sex with MSM and describe how the ADVANCE study will inform the FDA’s decision to move towards individualized risk assessment of donors which fosters inclusivity and respect.
- Explain why pre-exposure prophylaxis (PrEP) drugs impact donor deferral.
- Discuss donor eligibility issues for gender non-conforming donors and describe Innovative Blood Resources approach to overcoming these challenges.
Other eLearning Courses Available
Acute Transfusion Reactions: From Detection to Reporting
Author: Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 0.5
Level of Instruction: Intermediate
Course Objectives:
- Learn the following aspects of acute transfusion reactions: signs & symptoms, pathogenesis, lab findings, treatment & prevention.
- Identify procedures used to investigate acute transfusion reactions.
- Describe the use of the Hemovigilance Module for reporting purposes.
Adverse Transfusion Event Case Studies: Part 1, Pulmonary Transfusion Reactions
Author: Nancy Van Buren, MD & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Discuss the CBC National Healthcare Safety Network (NHSN) criteria for classifying adverse transfusion events.
- Describe the NHSN case definitions of TRALI, TACO and TAD.
- Evaluate the information presented in the case studies to identify the type of pulmonary adverse transfusion event and apply the appropriate CBC NHSN definition criteria.
Adverse Transfusion Event Case Studies: Part 2, Non-Pulmonary Transfusion Reactions
Author: Nancy Van Buren, MD & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Discuss the CDC National Healthcare Safety Network (NHSN) criteria for classifying adverse transfusion events.
- Describe the signs and symptoms of adverse transfusion events presented in case studies.
- Evaluate the information presented in the case studies to identify the type of adverse transfusion event and apply the appropriate CDC NHSN case definition criteria.
Autoimmune Hemolytic Anemia
Author: Nancy Van Buren, MD & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Leve of Instruction: Intermediate
Course Objectives:
- Identify the clinical presentations, causes and subtypes of autoimmune hemolytic anemia.
- Describe the role of the Direct Antiglobulin Test in the serologic evaluation of autoimmune hemolytic anemia.
- Discuss treatment and transfusion management.
Chronic Transfusion Therapy Program: Focus on Sickle Cell Disease
Author: Nancy Van Buren, MD & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Course Objectives:
- Explain the etiology of sickle cell disease and discuss the transfusion options and transfusion complications in this population.
- Identify the American Society of Hematology 2020 guidelines for transfusion support for sickle cell disease.
- Discuss the role of genotyping and antigen-matched blood for sickle cell patients in a chronic transfusion therapy program.
Common Blood Groups
Author: Lynsi Rahorst, MHPE, MLS(ASCP)SBBCM & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Define characteristics of common blood group antigens and antibodies.
- Determine the clinical significance of antibodies to common blood group antigens.
- Select appropriate units for transfusion in case scenarios.
Delayed Transfusion Reactions: From Detection to Reporting
Author: Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 0.5
Level of Instruction: Intermediate
Course Objectives:
- Describe the following aspects of delayed transfusion reactions: signs & symptoms, pathogenesis, lab findings, treatment & prevention.
- Identify procedures used to investigate delayed transfusion reactions.
- Describe the use of the Hemovigilance Module for reporting purposes.
Rh Antibodies as a Result of Altered Rh Epitopes on Transfused Red Blood Cells
Author: Megan Dupont, MLS(ASCP)CMSBBCM
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Discuss the strategies to reduce alloimmunization in chronically transfused patients.
- Define RH variant alleles and describe how variants may impact patients.
- Describe the investigation of a patient in which Rh antibody was produced despite selection of prophylactic matched red cells
The Basics of Patient Blood Management
Author: Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours:0.5
Level of Instruction: Intermediate
Course Objectives:
- Define patient blood management.
- Identify the goals and guidelines of patient blood management.
- Describe the purpose of the “Choosing Wisely” initiative.